Asian journal of endoscopic surgery · 2026
Optimal Timing of Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage in High-Risk Acute Cholecystitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nakagawa Yutaro, Ito Shuhei, Ishii Fuminori, Ureshino Hiroki, Hara Sohsuke, Kawabata Kouta, Kitano Masato, Nakahara Kozue, Yamazaki Ryo, Hanaoka Katsuzo, Hosoda Yasuhito, Nakamura Ren, Komiya Kazune, Maki Kenji, Morimoto Mitsuaki, Yoshida Yasushi, Inada Kazuo, Yanagisawa Jun, Noritomi Tomoaki
Аннотация
INTRODUCTION: The Tokyo Guidelines 2018 recommend early laparoscopic cholecystectomy for acute cholecystitis once the diagnosis is made. In surgical high-risk patients, however, initial management with antibiotics and gallbladder drainage is advised, followed by standby surgery. The optimal timing of standby surgery after percutaneous transhepatic gallbladder drainage remains unclear. This study aimed to evaluate the timing of standby cholecystectomy after gallbladder drainage in surgical high-risk patients.
METHODS: We retrospectively reviewed 97 patients who underwent cholecystectomy after percutaneous transhepatic gallbladder drainage between January 2019 and July 2024 at our hospital. Patients were classified as surgical high-risk (n = 56) or low-risk (n = 41) according to the Tokyo Guidelines 2018. In the high-risk group, both the total cohort and a propensity score-matched cohort (n = 22) were analyzed, comparing an early group (surgery within 7 days after gallbladder drainage) and a delay group (surgery ≥ 8 days); patients with Grade III acute cholecystitis were excluded before matching. Clinical characteristics and surgical outcomes were compared.
RESULTS: In the total cohort, C-reactive protein levels at initial presentation were significantly higher in the delay group (p < 0.05). All patients with Grade III acute cholecystitis (n = 9) were included in the delay group. In the matched cohort, surgical outcomes did not differ significantly between groups. However, total hospitalization was significantly shorter in the early group (p < 0.05).
CONCLUSIONS: In surgical high-risk patients, standby surgery within 7 days after percutaneous transhepatic gallbladder drainage may be preferable, as it shortens hospitalization without compromising surgical outcomes.
METHODS: We retrospectively reviewed 97 patients who underwent cholecystectomy after percutaneous transhepatic gallbladder drainage between January 2019 and July 2024 at our hospital. Patients were classified as surgical high-risk (n = 56) or low-risk (n = 41) according to the Tokyo Guidelines 2018. In the high-risk group, both the total cohort and a propensity score-matched cohort (n = 22) were analyzed, comparing an early group (surgery within 7 days after gallbladder drainage) and a delay group (surgery ≥ 8 days); patients with Grade III acute cholecystitis were excluded before matching. Clinical characteristics and surgical outcomes were compared.
RESULTS: In the total cohort, C-reactive protein levels at initial presentation were significantly higher in the delay group (p < 0.05). All patients with Grade III acute cholecystitis (n = 9) were included in the delay group. In the matched cohort, surgical outcomes did not differ significantly between groups. However, total hospitalization was significantly shorter in the early group (p < 0.05).
CONCLUSIONS: In surgical high-risk patients, standby surgery within 7 days after percutaneous transhepatic gallbladder drainage may be preferable, as it shortens hospitalization without compromising surgical outcomes.